Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancer.

Gupta S, Neumeister V, McGuire J, Song YS, Acs B, Ho K, Weidler J, Wong W, Rhees B, Bates M, Rimm DL, Bossuyt V.

NPJ Breast Cancer. 2019 Aug 29;5:28. doi: 10.1038/s41523-019-0122-x. eCollection 2019.

2.

Mast cells enhance sterile inflammation in chronic nonbacterial osteomyelitis.

Young S, Sharma N, Lee JH, Chitu V, Neumeister V, Sohr E, Stanley ER, Hedrich CM, Craig AWB.

Dis Model Mech. 2019 Aug 20;12(8). pii: dmm040097. doi: 10.1242/dmm.040097.

3.

Molecular and Clinical Activity of CDX-3379, an Anti-ErbB3 Monoclonal Antibody, in Head and Neck Squamous Cell Carcinoma Patients.

Duvvuri U, George J, Kim S, Alvarado D, Neumeister VM, Chenna A, Gedrich R, Hawthorne T, LaVallee T, Grandis JR, Bauman JE.

Clin Cancer Res. 2019 Oct 1;25(19):5752-5758. doi: 10.1158/1078-0432.CCR-18-3453. Epub 2019 Jul 15.

PMID:
31308059
4.

PTEN loss is associated with resistance to cetuximab in patients with head and neck squamous cell carcinoma.

Eze N, Lee JW, Yang DH, Zhu F, Neumeister V, Sandoval-Schaefer T, Mehra R, Ridge JA, Forastiere A, Chung CH, Burtness B.

Oral Oncol. 2019 Apr;91:69-78. doi: 10.1016/j.oraloncology.2019.02.026. Epub 2019 Mar 4.

PMID:
30926065
5.

Tumor Pre-Analytics in Molecular Pathology: Impact on Protein Expression and Analysis.

Neumeister VM, Juhl H.

Curr Pathobiol Rep. 2018;6(4):265-274. doi: 10.1007/s40139-018-0179-5. Epub 2018 Sep 6. Review.

6.

Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805.

Jilaveanu LB, Puligandla M, Weiss SA, Wang XV, Zito C, Flaherty KT, Boeke M, Neumeister V, Camp RL, Adeniran A, Pins M, Manola J, DiPaola RS, Haas NB, Kluger HM.

Clin Cancer Res. 2018 Jan 1;24(1):217-223. doi: 10.1158/1078-0432.CCR-17-1555. Epub 2017 Oct 24.

7.

High concordance of a closed-system, RT-qPCR breast cancer assay for HER2 mRNA, compared to clinically determined immunohistochemistry, fluorescence in situ hybridization, and quantitative immunofluorescence.

Wasserman BE, Carvajal-Hausdorf DE, Ho K, Wong W, Wu N, Chu VC, Lai EW, Weidler JM, Bates M, Neumeister V, Rimm DL.

Lab Invest. 2017 Dec;97(12):1521-1526. doi: 10.1038/labinvest.2017.93. Epub 2017 Sep 11.

8.

Aldehyde dehydrogenase 1B1: a novel immunohistological marker for colorectal cancer.

Matsumoto A, Arcaroli J, Chen Y, Gasparetto M, Neumeister V, Thompson DC, Singh S, Smith C, Messersmith W, Vasiliou V.

Br J Cancer. 2017 Nov 7;117(10):1537-1543. doi: 10.1038/bjc.2017.304. Epub 2017 Sep 7.

9.

ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC.

Alvarado D, Ligon GF, Lillquist JS, Seibel SB, Wallweber G, Neumeister VM, Rimm DL, McMahon G, LaVallee TM.

PLoS One. 2017 Jul 19;12(7):e0181356. doi: 10.1371/journal.pone.0181356. eCollection 2017.

10.

The ABCs of finding a good antibody: How to find a good antibody, validate it, and publish meaningful data.

Acharya P, Quinlan A, Neumeister V.

F1000Res. 2017 Jun 8;6:851. doi: 10.12688/f1000research.11774.1. eCollection 2017.

11.

Nuclear IRF-1 expression as a mechanism to assess "Capability" to express PD-L1 and response to PD-1 therapy in metastatic melanoma.

Smithy JW, Moore LM, Pelekanou V, Rehman J, Gaule P, Wong PF, Neumeister VM, Sznol M, Kluger HM, Rimm DL.

J Immunother Cancer. 2017 Mar 21;5:25. doi: 10.1186/s40425-017-0229-2. eCollection 2017.

12.

A Quantitative Comparison of Antibodies to Programmed Cell Death 1 Ligand 1.

Gaule P, Smithy JW, Toki M, Rehman J, Patell-Socha F, Cougot D, Collin P, Morrill P, Neumeister V, Rimm DL.

JAMA Oncol. 2017 Feb 1;3(2):256-259. doi: 10.1001/jamaoncol.2016.3015.

13.

Automated measurement of estrogen receptor in breast cancer: a comparison of fluorescent and chromogenic methods of measurement.

Zarrella ER, Coulter M, Welsh AW, Carvajal DE, Schalper KA, Harigopal M, Rimm DL, Neumeister VM.

Lab Invest. 2016 Sep;96(9):1016-25. doi: 10.1038/labinvest.2016.73. Epub 2016 Jun 27.

14.

Safety and tolerability during build-up phase of a rush venom immunotherapy.

Bernkopf K, Rönsch H, Spornraft-Ragaller P, Neumeister V, Bauer A.

Ann Allergy Asthma Immunol. 2016 Apr;116(4):360-5. doi: 10.1016/j.anai.2016.02.014.

PMID:
27055991
15.

Comparison of the expression of vimentin and actin in spitz nevi and spitzoid malignant melanomas.

Alomari AK, Klump V, Neumeister V, Ariyan S, Narayan D, Lazova R.

Am J Dermatopathol. 2015 Jan;37(1):46-51. doi: 10.1097/DAD.0000000000000147.

PMID:
25548991
16.

Quantitative measurement of cancer tissue biomarkers in the lab and in the clinic.

Carvajal-Hausdorf DE, Schalper KA, Neumeister VM, Rimm DL.

Lab Invest. 2015 Apr;95(4):385-96. doi: 10.1038/labinvest.2014.157. Epub 2014 Dec 15. Review.

17.

Preanalytical variables and phosphoepitope expression in FFPE tissue: quantitative epitope assessment after variable cold ischemic time.

Vassilakopoulou M, Parisi F, Siddiqui S, England AM, Zarella ER, Anagnostou V, Kluger Y, Hicks DG, Rimm DL, Neumeister VM.

Lab Invest. 2015 Mar;95(3):334-41. doi: 10.1038/labinvest.2014.139. Epub 2014 Nov 24.

18.

In situ quantitative measurement of HER2mRNA predicts benefit from trastuzumab-containing chemotherapy in a cohort of metastatic breast cancer patients.

Vassilakopoulou M, Togun T, Dafni U, Cheng H, Bordeaux J, Neumeister VM, Bobos M, Pentheroudakis G, Skarlos DV, Pectasides D, Kotoula V, Fountzilas G, Rimm DL, Psyrri A.

PLoS One. 2014 Jun 26;9(6):e99131. doi: 10.1371/journal.pone.0099131. eCollection 2014.

19.

Tools to assess tissue quality.

Neumeister VM.

Clin Biochem. 2014 Mar;47(4-5):280-7. doi: 10.1016/j.clinbiochem.2014.02.016. Epub 2014 Feb 22. Review.

PMID:
24565988
20.

A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue.

Neumeister VM, Parisi F, England AM, Siddiqui S, Anagnostou V, Zarrella E, Vassilakopolou M, Bai Y, Saylor S, Sapino A, Kluger Y, Hicks DG, Bussolati G, Kwei S, Rimm DL.

Lab Invest. 2014 Apr;94(4):467-74. doi: 10.1038/labinvest.2014.7. Epub 2014 Feb 17.

21.

Comparison of HER2 and phospho-HER2 expression between biopsy and resected breast cancer specimens using a quantitative assessment method.

Bai Y, Cheng H, Bordeaux J, Neumeister V, Kumar S, Rimm DL, Stern DF.

PLoS One. 2013 Nov 21;8(11):e79901. doi: 10.1371/journal.pone.0079901. eCollection 2013.

22.

Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues.

Neumeister VM, Anagnostou V, Siddiqui S, England AM, Zarrella ER, Vassilakopoulou M, Parisi F, Kluger Y, Hicks DG, Rimm DL.

J Natl Cancer Inst. 2012 Dec 5;104(23):1815-24. doi: 10.1093/jnci/djs438. Epub 2012 Oct 22.

23.

Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer.

Neumeister VM, Sullivan CA, Lindner R, Lezon-Geyda K, Li J, Zavada J, Martel M, Glazer PM, Tuck DP, Rimm DL, Harris L.

Breast Cancer Res Treat. 2012 Nov;136(1):67-75. doi: 10.1007/s10549-012-2232-0. Epub 2012 Sep 14.

PMID:
22976806
24.

Measurement of aldehyde dehydrogenase 1 expression defines a group with better prognosis in patients with non-small cell lung cancer.

Dimou A, Neumeister V, Agarwal S, Anagnostou V, Syrigos K, Rimm DL.

Am J Pathol. 2012 Oct;181(4):1436-42. doi: 10.1016/j.ajpath.2012.06.037. Epub 2012 Aug 8.

PMID:
22877687
25.

Lin28 regulates HER2 and promotes malignancy through multiple mechanisms.

Feng C, Neumeister V, Ma W, Xu J, Lu L, Bordeaux J, Maihle NJ, Rimm DL, Huang Y.

Cell Cycle. 2012 Jul 1;11(13):2486-94. doi: 10.4161/cc.20893. Epub 2012 Jul 1.

PMID:
22713243
26.

Stathmin expression and its relationship to microtubule-associated protein tau and outcome in breast cancer.

Baquero MT, Hanna JA, Neumeister V, Cheng H, Molinaro AM, Harris LN, Rimm DL.

Cancer. 2012 Oct 1;118(19):4660-9. doi: 10.1002/cncr.27453. Epub 2012 Feb 22.

27.

Serum levels of secreted group IIA phospholipase A(2) in benign prostatic hyperplasia and prostate cancer: a biomarker for inflammation or neoplasia?

Menschikowski M, Hagelgans A, Fuessel S, Mareninova OA, Neumeister V, Wirth MP, Siegert G.

Inflammation. 2012 Jun;35(3):1113-8. doi: 10.1007/s10753-011-9418-1.

PMID:
22189868
28.

Utility of measuring vitamin B12 and its active fraction, holotranscobalamin, in neurological vitamin B12 deficiency syndromes.

Schrempf W, Eulitz M, Neumeister V, Siegert G, Koch R, Reichmann H, Storch A.

J Neurol. 2011 Mar;258(3):393-401. doi: 10.1007/s00415-010-5764-4. Epub 2010 Oct 2.

PMID:
20890610
29.

In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis.

Neumeister V, Agarwal S, Bordeaux J, Camp RL, Rimm DL.

Am J Pathol. 2010 May;176(5):2131-8. doi: 10.2353/ajpath.2010.090712. Epub 2010 Mar 12.

30.

Is ALDH1 a good method for definition of breast cancer stem cells?

Neumeister V, Rimm D.

Breast Cancer Res Treat. 2010 Aug;123(1):109-11. doi: 10.1007/s10549-009-0656-y. Epub 2009 Nov 28. No abstract available.

PMID:
19946740
31.

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.

Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A, Rimm DL, Wong H, Rodriguez A, Herschkowitz JI, Fan C, Zhang X, He X, Pavlick A, Gutierrez MC, Renshaw L, Larionov AA, Faratian D, Hilsenbeck SG, Perou CM, Lewis MT, Rosen JM, Chang JC.

Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13820-5. doi: 10.1073/pnas.0905718106. Epub 2009 Aug 3.

32.

A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers.

Camp RL, Neumeister V, Rimm DL.

J Clin Oncol. 2008 Dec 1;26(34):5630-7. doi: 10.1200/JCO.2008.17.3567. Epub 2008 Oct 20. Review.

PMID:
18936473
33.

Exhaled breath condensate nitrite--methodological problems of sample collection.

Vogelberg C, Kahlert A, Würfel C, Marx K, Böhm A, Range U, Neumeister V, Leupold W.

Med Sci Monit. 2008 Aug;14(8):CR416-22.

PMID:
18667999
34.

Multicentre evaluation of performance of C-reactive protein analysis over a one-year period.

Bewarder N, Abmeier F, Bergmann S, Drohla S, Drescher V, Gerstmeyer A, Kuss S, Melamies L, Miksch R, Ortin V, Rietschel-Klein A, Neumeister V, Odarjuk J, Stratmann MM, Weinhold A, Wiesner B, Wildbredt DA, Wollenberg P, Zinsmeyer J, Zogbaum M, Zwerenz P, Zwirner M, Wood WG.

Clin Lab. 2006;52(11-12):639-54.

PMID:
17175896
35.

Exposure to chromium, cobalt and molybdenum from metal-on-metal total hip replacement and hip resurfacing arthroplasty.

Witzleb WC, Ziegler J, Krummenauer F, Neumeister V, Guenther KP.

Acta Orthop. 2006 Oct;77(5):697-705.

PMID:
17068698
36.

Statins potentiate the IFN-gamma-induced upregulation of group IIA phospholipase A2 in human aortic smooth muscle cells and HepG2 hepatoma cells.

Menschikowski M, Hagelgans A, Heyne B, Hempel U, Neumeister V, Goez P, Jaross W, Siegert G.

Biochim Biophys Acta. 2005 Apr 15;1733(2-3):157-71. Epub 2005 Jan 22.

PMID:
15863363
37.

Hydrophilic interaction chromatography combined with tandem-mass spectrometry to determine six aminoglycosides in serum.

Oertel R, Neumeister V, Kirch W.

J Chromatogr A. 2004 Nov 26;1058(1-2):197-201.

PMID:
15595668
38.

Exocrine pancreatic insufficiency and its consequences on physical development and metabolism in children and adolescents with type 1 diabetes mellitus.

Laass MW, Henker J, Thamm K, Neumeister V, Kuhlisch E.

Eur J Pediatr. 2004 Nov;163(11):681-2. Epub 2004 Aug 6. No abstract available.

PMID:
15300430
39.
40.

Total fluoride intake and urinary excretion in German children aged 3-6 years.

Haftenberger M, Viergutz G, Neumeister V, Hetzer G.

Caries Res. 2001 Nov-Dec;35(6):451-7.

PMID:
11799286
41.

Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy.

Guenther PP, Huebner A, Sobottka SB, Neumeister V, Weissbach G, Todt H, Parwaresch R.

J Pediatr Hematol Oncol. 2001 Feb;23(2):134-8.

PMID:
11216707
42.

Traffic exposure and allergic sensitization against latex in children.

Hirsch T, Neumeister V, Weiland SK, von Mutius E, Hirsch D, Gräfe H, Duhme H, Leupold W.

J Allergy Clin Immunol. 2000 Sep;106(3):573-8.

PMID:
10984380
43.

Effect of digoxin on circadian blood pressure values in patients with congestive heart failure.

Kirch C, Grossmann M, Fischer S, Neumeister V, Kirch W.

Eur J Clin Invest. 2000 Apr;30(4):285-9.

PMID:
10759875
44.

Exposure and allergic sensitization to cockroach allergen in East Germany.

Hirsch T, Stappenbeck C, Neumeister V, Weiland SK, Von Mutius E, Keil U, Leupold W.

Clin Exp Allergy. 2000 Apr;30(4):529-37.

PMID:
10718850
45.

Determination of cholesterol in atherosclerotic plaques using near infrared diffuse reflection spectroscopy.

Jaross W, Neumeister V, Lattke P, Schuh D.

Atherosclerosis. 1999 Dec;147(2):327-37.

PMID:
10559519
46.
47.

Simultaneous determination of fecal fat, nitrogen, and water by near-infrared reflectance spectroscopy.

Neumeister V, Henker J, Kaltenborn G, Sprössig C, Jaross W.

J Pediatr Gastroenterol Nutr. 1997 Oct;25(4):388-93.

PMID:
9327368
48.

[Allergic bronchopulmonary aspergillosis (ABPA) in patients with cystic fibrosis (CF): clinical significance, diagnosis and therapy].

Paul KD, Leupold W, Blaschke-Hellmessen R, Ulbrich K, Peter-Kern M, Neumeister V.

Mycoses. 1996;39 Suppl 1:55-8. German.

PMID:
8767272

Supplemental Content

Loading ...
Support Center